Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
clinical trials
drugs
life sciences
national blog main
1923 births
1954 births
akcea therapeutics
american billionaires
american chief executives
american entertainment industry businesspeople
american jews
american mass media owners
american media executives
american military personnel of world war ii
anylam pharmaceuticals
boston blog main
boston latin school alumni
boston top stories
businesspeople from massachusetts
cannabidiol
cardiomyopathy
cbs corporation
columbia law school alumni
columbia university alumni
companies based in manhattan
companies established in 2006
companies listed on nasdaq
dravet syndrome
epidiolex
fda
fen-phen
fenfluramine
georgetown university law center alumni
gw pharmaceuticals
harvard law school alumni
inotersen
keck school of medicine of usc people
lennox-gastaut syndrome
living people
massachusetts
What
approved
3
×
battle
3
×
ago
drug
fda
rare
sets
akcea
alnylam
amyloidosis
attr
available
board
cannabis
data
dauman
debilitating
derivative
disease
epilepsy
family
form
genetic
gw
gw’s
marijuana
market
medicine
medicines
oks
patients
pfizer
pharmaceuticals
philippe
redstone
rt
settlement
transthyretin
update
viacom's
Language
Current search:
battle
×
approved
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@mathewi
7 years ago
RT @Lucas_Shaw: Update: Viacom's board has approved a settlement between the Redstone family and Philippe Dauman. The battle is over.
